Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PLoS Medicine

Volumn 9, Issue 12, 2012, Pages

  Elmunzer, B Joseph ^a   Hayward, Rodney A ^a   Schoenfeld, Philip S ^a   Saini, Sameer D ^a   Deshpande, Amar ^b   Waljee, Akbar K ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTAMINATION; FOLLOW UP; HUMAN; INCIDENCE; META ANALYSIS; POLYPECTOMY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIGMOIDOSCOPY;

EID: 84871666335     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001352     Document Type: Article

References (51)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Bandi P, Cokkinides V, Smith RA, Jemal A, (2012) Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008. Cancer 118: 5092-5099.
3. Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, et al. (2004) How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 127: 1670-1677.
4. Screening for colorectal cancer (2008) U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149: 627-637.
5. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595.
6. Muller AD, Sonnenberg A, (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123: 904-910.
7. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS, (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New Engl J Med 326: 653-657.
8. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New Engl J Med 329: 1977-1981.
9. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-1633.
10. Hoff G, Grotmol T, Skovlund E, Bretthauer M, (2009) Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338: b1846.
11. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, et al. (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med 366: 2345-2357.
12. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, et al. (2011) Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer I 103: 1310-1322.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012.
14. Schoenfeld P, Cook D, Hamilton F, Laine L, Morgan D, et al. (1998) An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group. Gastroenterology 114: 1318-1325.
15. Sussman JB, Hayward RA, (2010) An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 340: c2073.
16. Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, et al. (2012) Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 13: 55-64.
17. Juchems M, Rompp A, Kestler HA, Ernst A, Brambs HJ, et al. (2010) [A prospective comparison of video colonoscopy and CT colonography in asymptomatic patients screened for colorectal cancer]. Deutsche medizinische Wochenschrift 135: 1656-1661.
18. Khalid-de Bakker CA, Jonkers DM, Sanduleanu S, de Bruine AP, Meijer GA, et al. (2011) Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas. Cancer Prev Res 4: 1563-1571.
19. Elwood JM, Ali G, Schlup MM, McNoe B, Barbezat GO, et al. (1995) Flexible sigmoidoscopy or colonoscopy for colorectal screening: a randomized trial of performance and acceptability. Cancer Detect Prev 19: 337-347.
20. Parra-Blanco A, Gimeno-Garcia AZ, Quintero E, Nicolas D, Moreno SG, et al. (2010) Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 45: 703-712.
21. Parente F, Marino B, DeVecchi N, Moretti R, Ucci G, et al. (2009) Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg 96: 533-540.
22. Lisi D, Hassan C, Crespi M, (2010) Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Dig Liver Dis 42: 371-376.
23. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, et al. (2010) Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59: 62-68.
24. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, et al. (2007) Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132: 2304-2312.
25. Federici A, Marinacci C, Mangia M, Borgia P, Giorgi Rossi P, et al. (2006) Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Cancer Detect Prev 30: 347-353.
26. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, et al. (2005) Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer I 97: 989-997.
27. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, et al. (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer I 97: 347-357.
28. Maxwell AE, Bastani R, Crespi CM, Danao LL, Cayetano RT, (2011) Behavioral mediators of colorectal cancer screening in a randomized controlled intervention trial. Prev Med 52: 167-173.
29. Blom J, Yin L, Liden A, Dolk A, Jeppsson B, et al. (2008) A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection. Cancer Epidemiol Biomarkers Prev 17: 1163-1168.
30. Adler A, Roll S, Marowski B, Drossel R, Rehs HU, et al. (2007) Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum 50: 1628-1638.
31. Bleiberg H, Autier P, Huet F, Schrauwen AM, Staquet E, et al. (2006) Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population. Ann Oncol 17: 1328-1332.
32. Pabby A, Suneja A, Heeren T, Farraye FA, (2005) Flexible sigmoidoscopy for colorectal cancer screening in the elderly. Digest Dis Sci 50: 2147-2152.
33. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, et al. (2005) A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129: 422-428.
34. Canard JM, Debette-Gratien M, Dumas R, Escourrou J, Gay G, et al. (2005) A prospective national study on colonoscopy and sigmoidoscopy in 2000 in France. Gastroenterologie clinique et biologique 29: 17-22.
35. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD, (2003) Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer I 95: 622-625.
36. Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM, (1998) Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317: 182-185.
37. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, et al. (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. New Engl J Med 343: 162-168.
38. Schoen RE, Corle D, Cranston L, Weissfeld JL, Lance P, et al. (1998) Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology 115: 533-541.
39. Adler M, Demols A, Franchimont D, Van Laethem JL, Van Gossum A, (2001) [Screening for colorectal cancer by endoscopy: rectosigmoidoscopy or coloscopy?]. Revue medicale de Bruxelles 22: A210-213.
40. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, et al. (1999) Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I Scand J Gastroentero 34: 414-420.
41. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O, (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471.
42. Lindholm E, Brevinge H, Haglind E, (2008) Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 95: 1029-1036.
43. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New Engl J Med 328: 1365-1371.
44. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, et al. (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150: 1-8.
45. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, et al. (2010) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer I 102: 89-95.
46. Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN, (2010) Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 105: 663-673; quiz 674.
47. Thiis-Evensen E, Kaminski MF, Bretthauer M, (2011) First randomized trial of colonoscopy screening for the prevention of colorectal cancer. Gastrointest Endosc 73: AB159.
48. Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, et al. (2012) The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 44: 695-702.
49. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, et al. (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. New Engl J Med 366: 697-706.
50. Colonoscopy versus fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM). ClinicalTrials.gov Identifier: NCT01239082.
51. Elmunzer BJ, O'Connell MT, Prendes S, Saini SD, Sussman DA, et al. (2011) Improving access to colorectal cancer screening through medical philanthropy: feasibility of a flexible sigmoidoscopy health fair for uninsured patients. Am J Gastroenterol 106: 1741-1746.